Mohammad Alyami

3.5k total citations · 2 hit papers
45 papers, 1.2k citations indexed

About

Mohammad Alyami is a scholar working on Surgery, Emergency Medicine and Reproductive Medicine. According to data from OpenAlex, Mohammad Alyami has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 24 papers in Emergency Medicine and 13 papers in Reproductive Medicine. Recurrent topics in Mohammad Alyami's work include Intraperitoneal and Appendiceal Malignancies (35 papers), Appendicitis Diagnosis and Management (24 papers) and Ovarian cancer diagnosis and treatment (13 papers). Mohammad Alyami is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (35 papers), Appendicitis Diagnosis and Management (24 papers) and Ovarian cancer diagnosis and treatment (13 papers). Mohammad Alyami collaborates with scholars based in France, Saudi Arabia and Switzerland. Mohammad Alyami's co-authors include Olivier Gléhen, Naoual Bakrin, Guillaume Passot, Laurent Villeneuve, Vahan Képénékian, Martin Hübner, Nathalie Laplace, Olivia Sgarbură, Frédéric Mercier and Fabian Grass and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Mohammad Alyami

40 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications

2019 215 citations Mohammad Alyami, Martin Hübner et al. The Lancet Oncology profile →
Primary and metastatic peritoneal surface malignancies

2021 166 citations Delia Cortés‐Guiral, Martin Hübner et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohammad Alyami France	19	985	495	382	273	167	45	1.2k
Vahan Képénékian France	19	1.1k 1.1×	566 1.1×	467 1.2×	310 1.1×	178 1.1×	87	1.4k
Kurt Van der Speeten Belgium	22	1.1k 1.1×	584 1.2×	515 1.3×	234 0.9×	194 1.2×	55	1.4k
Jack Porcheron France	10	1.0k 1.0×	518 1.0×	399 1.0×	209 0.8×	175 1.0×	16	1.2k
Marco Vaira Italy	18	859 0.9×	500 1.0×	428 1.1×	170 0.6×	107 0.6×	65	1.0k
Jürgen Zieren Germany	19	1.1k 1.2×	459 0.9×	305 0.8×	259 0.9×	94 0.6×	33	1.3k
Naoual Bakrin France	24	1.6k 1.7×	891 1.8×	879 2.3×	335 1.2×	175 1.0×	85	1.9k
Annie C. Beaujard France	9	1.3k 1.3×	722 1.5×	609 1.6×	221 0.8×	162 1.0×	13	1.4k
F.N. Gilly France	9	1.5k 1.5×	849 1.7×	619 1.6×	232 0.8×	174 1.0×	22	1.6k
J. Porcheron France	11	1.4k 1.4×	786 1.6×	572 1.5×	158 0.6×	121 0.7×	35	1.5k
Eric Fontaumard France	6	946 1.0×	517 1.0×	397 1.0×	170 0.6×	125 0.7×	8	1.0k

Countries citing papers authored by Mohammad Alyami

Since Specialization

Citations

This map shows the geographic impact of Mohammad Alyami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Alyami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Alyami more than expected).

Fields of papers citing papers by Mohammad Alyami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Alyami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Alyami. The network helps show where Mohammad Alyami may publish in the future.

Co-authorship network of co-authors of Mohammad Alyami

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Alyami. A scholar is included among the top collaborators of Mohammad Alyami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Alyami. Mohammad Alyami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aldhahir, Abdulelah M., Abdullah A. Alqarni, Rayan A. Siraj, et al.. (2025). Spirometry Profiles of Overweight and Obese Individuals With Unexplained Dyspnea. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1489–A1489.

Alyami, Mohammad, et al.. (2025). Treatment Modalities and Survival Outcomes in Gastric Cancer: Insights From Najran, Saudi Arabia. Cureus. 17(2). e79649–e79649.

Alyami, Mohammad, et al.. (2024). Prevalence of multidrug-, extensively drug-, and pandrug-resistant bacteria in clinical isolates from King Khaled Hospital, Najran, Saudi Arabia. Discover Medicine. 1(1). 3 indexed citations

Alyami, Mohammad, et al.. (2024). Robotic and Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, Multicenter Study From Saudi Arabia. Journal of Surgical Oncology. 130(6). 1326–1331. 1 indexed citations

Taïbi, Abdelkader, Olivia Sgarbură, Martin Hübner, et al.. (2022). Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study. Annals of Surgical Oncology. 29(8). 5243–5251. 20 indexed citations

Képénékian, Vahan, Aditi Bhatt, Julien Péron, et al.. (2022). Advances in the management of peritoneal malignancies. Nature Reviews Clinical Oncology. 19(11). 698–718. 48 indexed citations

Cortés‐Guiral, Delia, Olivia Sgarbură, Mohammad Alyami, et al.. (2021). Priorities, actions and risks in the COVID-19 pandemic: a flash SoMe survey among surgical oncologists. PubMed. 6(1). 7–12. 1 indexed citations

Képénékian, Vahan, Julien Péron, Benoît You, et al.. (2021). Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study. Annals of Surgical Oncology. 29(3). 2104–2113. 14 indexed citations

Cortés‐Guiral, Delia, Martin Hübner, Mohammad Alyami, et al.. (2021). Primary and metastatic peritoneal surface malignancies. Nature Reviews Disease Primers. 7(1). 91–91. 166 indexed citations breakdown →

10.

Alyami, Mohammad, Pierre‐Emmanuel Bonnot, Frédéric Mercier, et al.. (2020). Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. European Journal of Surgical Oncology. 47(1). 123–127. 76 indexed citations

11.

Alyami, Mohammad, Martin Hübner, Fabian Grass, et al.. (2019). Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. The Lancet Oncology. 20(7). e368–e377. 215 indexed citations breakdown →

12.

Eisenga, Michele F., Mohammad Alyami, Mohamed R. Daha, et al.. (2019). Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients. Frontiers in Immunology. 10. 2511–2511. 16 indexed citations

13.

Mercier, Frédéric, et al.. (2019). Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma. Surgical Endoscopy. 34(11). 4916–4923. 20 indexed citations

14.

Sgarbură, Olivia, Martin Hübner, Mohammad Alyami, et al.. (2019). Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study. European Journal of Surgical Oncology. 45(12). 2386–2391. 47 indexed citations

15.

Tavernier, C., Guillaume Passot, Bernard Allaouchiche, et al.. (2019). Pressurized intraperitoneal aerosol chemotherapy (PIPAC) might increase the risk of anastomotic leakage compared to HIPEC: an experimental study. Surgical Endoscopy. 34(7). 2939–2946. 9 indexed citations

16.

Alyami, Mohammad, Frédéric Mercier, Nicolas Vantard, et al.. (2018). No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis. Anticancer Research. 38(12). 6869–6875. 14 indexed citations

17.

Nowacki, Maciej, Mohammad Alyami, Laurent Villeneuve, et al.. (2018). Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. European Journal of Surgical Oncology. 44(7). 991–996. 72 indexed citations

18.

Alyami, Mohammad, Frédéric Mercier, Laurent Villeneuve, et al.. (2018). Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report. Cancer Chemotherapy and Pharmacology. 83(3). 425–430. 18 indexed citations

19.

Alyami, Mohammad, et al.. (2018). Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for nonresectable peritoneal carcinomatosis from gastric cancer.. Journal of Clinical Oncology. 36(4_suppl). 149–149. 4 indexed citations

20.

Alyami, Mohammad, et al.. (2017). Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Non-resectable Peritoneal Carcinomatosis (with Video). Journal of Gastrointestinal Surgery. 22(2). 374–375. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact